<unk>  (Zeftera/Zevtera) is a fifth-generation cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, Pseudomonas aeruginosa, and enterococci.  It was discovered by Basilea Pharmaceutica and was developed by Johnson & Johnson Pharmaceutical Research and Development.  It has been shown to be statistically noninferior to the combination of vancomycin and ceftazidime for the treatment of skin and soft tissue infections.
It has been described as a fifth-generation cephalosporin, though acceptance for this terminology is not universal.
Ceftobiprole medocaril
Ketobemidone
Telotristat ethyl
Solriamfetol
Fluphenazine Hydrochloride
Bedaquiline fumarate
Lisdexamfetamine
Bunaftine